Investors

Webcast ImageWebcast - Replay
Q2 2016 Array BioPharma Inc. Earnings Conference Call
02/02/16 at 9:00 a.m. ET
Webcast ImageWebcast - Live
Array BioPharma Inc. at Leerink Partners Annual Global Healthcare Conference
02/10/16 at 8:00 a.m. ET
Profile

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Six Phase 3 studies are currently advancing. These programs include three cancer drugs, binimetinib (MEK162), encorafenib (LGX818) and selumetinib (partnered with AstraZeneca).

Array BioPharma
Fact Sheet

Array BioPharma
2015 Annual Report

Array BioPharma
Investor Presentation

Stock Quote & Chart

ARRY (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$2.91
Change (%) Stock is Down 0.11 (3.64%)
Volume2,600,963
Data as of 02/05/16 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
 
Stock chart for: 03NA000000ARRY
Recent NewsMore >>

Upcoming Events

More >>
DateTitle
02/10/16 8:00 a.m. ET
Array BioPharma Inc. at Leerink Partners Annual Global Healthcare Conference
LocationNew York, NY
Primary IR Contacts
Tricia Haugeto
Director, Corporate Communications and Investor Relations
Phone: (303) 386-1193
E-mail: Tricia.Haugeto@arraybiopharma.com

Transfer Agent
American Stock Transfer and Trust Company
6201 15th Avenue
Brooklyn, NY 11219
Phone: (800) 937-5449
Fax: (718) 236-4588
E-mail: Info@amstock.com
Website: http://www.amstock.com

Legal
Gross Cutler Seiler Dupont LLC
1877 Broadway, Suite 601
Boulder, CO 80302
Phone: (303) 926-4823

Accountants
KPMG LLP
707 Seventeenth Street, Suite 2700
Denver, CO 80202
Phone: (303) 295-5572


Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.